MedTrace Logo

A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias

NCT04660630 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1172

Last updated 2020-12-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness, safety and health economics of precise drug use strategies based on pharmacogenomics compared with traditional drug use strategies for cardiovascular related chronic diseases.

Conditions

  • Hypertension,Essential
  • Diabetes type2
  • Hyperlipidemias

Interventions

DIAGNOSTIC_TEST

Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases

According to the results of drug gene chip detection, we combined with the clinical characteristics of the patient to choose more suitable cardiovascular and cerebrovascular treatment drugs.

BEHAVIORAL

Regular follow-up and patient education

The subjects received regular follow-up and patient education.

Sponsors & Collaborators

  • China development research foundation

    collaborator UNKNOWN

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Lihong Liu, Doctor · Beijing Chao Yang Hospital

  • Yue Qiu, Doctor · China development research foundation

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
55 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2023-12-20
Completion
2025-01-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04660630 on ClinicalTrials.gov